-Peggy H Love love love this place
More than half (55%) of the population was male
peaks during dose escalation, typically mild-moderate Diarrhea -- 10-20%, usually transient Constipation -- 8-15% Vomiting -- 5-15%, more frequent at higher doses Injection site reactions -- 5-10%, mild erythema and pruritus Decreased appetite -- 5-12%, related to mechanism of action Pancreatitis -- rare but monitored (as with all GLP-1/amylin agents) Gallbladder events -- cholelithiasis reported, consistent with rapid weight loss Trial data describes dose titration as central to tolerability -- the 16-week escalation protocol substantially reduced GI adverse events
Employers seek solutions While these drugs represent a small fraction of prescriptions, their financial impact is outsized
This therapy improves the radiance of your skin, reduces the signs of aging and improves your overall health
Neuropharmacology 251, 109929